Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin for Lower Extremity Spasticity in MS
NCT01968902Phase 4Completed
- Start
- Nov 2013
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in Spasticity. Started Nov 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT01968902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968902.